Chronic stimulation desensitizes β2‐adrenergic receptor responses in natural killer cells
European Journal of Immunology · 2024
DOI: 10.1002/eji.202451299 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Martin Jürgens und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department for Immunology, Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund, Dortmund, Germany. Hauptthemen laut MEDLINE: Killer Cells, Natural, Receptors, Adrenergic, beta-2, Epinephrine, Adrenergic beta-2 Receptor Agonists. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Adrenergic receptors (ARs) are preferentially expressed by innate lymphocytes such as natural killer (NK) cells. Here, we study the effect of epinephrine‐mediated stimulation of the β2‐adrenergic receptor (β2AR) on the function of human NK cells. Epinephrine stimulation inhibited early NK cell signaling events and blocked the function of the integrin LFA‐1. This reduced the adhesion of NK cells to ICAM‐1, explaining how NK cells are mobilized into the peripheral blood upon epinephrine release during acute stress or exercise. Additionally, epinephrine stimulation transiently reduced NK cell degranulation, serial killing, and cytokine production and affected metabolic changes upon NK cell activation via the cAMP‐protein kinase A (PKA) pathway. Repeated exposure to β2AR agonists resulted in the desensitization of the β2AR via a PKA feedback loop‐initiated G‐protein switch. Therefore, acute epinephrine stimulation of chronically β2AR stimulated NK cells no longer resulted in inhibited signaling and reduced LFA‐1 activity. Sustained stimulation by long‐acting β2‐agonists (LABA) not only inhibited NK cell functions but also resulted in desensitization of the β2AR. However, peripheral NK cells from LABA‐treated asthma patients still reacted unchanged to epinephrine stimulation, demonstrating that local LABA administration does not result in detectable systemic effects on NK cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for Immunology, Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund, Dortmund, Germany.
- Max Planck Institute of Molecular Physiology, Dortmund, Germany.
- Department of Pulmonary Medicine, University Medicine Essen-University Hospital-Ruhrlandklinik, Essen, Germany.
- Department of Statistics, TU Dortmund University, Dortmund, Germany.
- Analytical Chemistry, Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund, Dortmund, Germany.
- Department of Pulmonary Medicine, University Medicine Essen-University Hospital, Essen, Germany.
ORCID-Profile: Maren Claus, Carsten Watzl
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Jürgens, M., Claus, M., Wingert, S., Niemann, J. A., Picard, L. K., Hennes, E., Haasler, I., Hellwig, B., Overbeck, N., Reinders, J., Rahnenführer, J., Schedel, M., Capellino, S., & Watzl, C. (2024). Chronic stimulation desensitizes β2‐adrenergic receptor responses in natural killer cells. European Journal of Immunology. https://doi.org/10.1002/eji.202451299
Vancouver
Jürgens M, Claus M, Wingert S, Niemann JA, Picard LK, Hennes E, et al. Chronic stimulation desensitizes β2‐adrenergic receptor responses in natural killer cells. European Journal of Immunology. 2024. doi:10.1002/eji.202451299
BibTeX
@article{Jrgens2024,
author = {Jürgens, Martin and Claus, Maren and Wingert, Sabine and Niemann, Jens Alexander and Picard, Lea Katharina and Hennes, Elisabeth and Haasler, Ina and Hellwig, Birte and Overbeck, Nina and Reinders, Jörg and Rahnenführer, Jörg and Schedel, Michaela and Capellino, Silvia and Watzl, Carsten},
title = {Chronic stimulation desensitizes β2‐adrenergic receptor responses in natural killer cells},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202451299}
}
EUVIMED